CUNY United States

CUNY is home to more than 100 research centers, institutes and consortia, which provide research opportunities for faculty and students, employment, internships, and special events. These centers focus their efforts on a wide range of areas, including aging, applied sciences, corporate integrity, transportation systems, ethnic studies, performing arts, sustainable energy and urban studies, to name a few.

Many institutions reflect CUNY’s support of state-of-the-art education and research, such as the Institute for Ultrafast Spectroscopy and Lasers. Others exemplify the University’s commitment to service and historic preservation, including the Institute for Criminal Justice Ethics at John Jay College and the Gotham Center for New York City History, founded by Pulitzer Prize-winning historian Mike Wallace.


CUNY United States

Ms Neeti Mitra
University Research Commercialization Manager 

CUNY Institute CoSSMO United States

Our mission is to identify potential projects and participants across CUNY and in the community at large, to help members identify sources of funding and to prepare grant applications, to facilitate the execution of the projects, providing advice, space, and computer facilities, to create research programs by aggregating multiple projects with common defining factors (such programs will promote interactions and networking that will increase the value of the research activities with respect to the contribution of individual projects), to manage program projects with core competencies, and to establish collaborations outside CUNY (national and international)

Professor Felisa Vazquez-Abad
Professor and Executive Director 

CUNY-CITY COLLEGE | the Advanced Vein Visualization, AVV-1 United States

IUSL /Physics Dept. Outcome in Biophotonics Developed at the City University of New York and Lawrence Livermore National Laboratory, the Advanced Vein Visualization, AVV-1 provides a superior illumination and visualization of a patient's veins in both the arm and hand.  The AVV-1 has been designed to help a medical practitioner or nurse to accomplish the task of inserting a needle for an IV or blood draw in a more efficient, timely and safe manner. This will help minimize patient and practitioner stress, treatment delays, and infections from failed attempts. Vein illumination is particularly important when the patient is obese, very young, aged and/or has dark skin. Hopefully, the AVV-1 will soon be on the market at blood test centers and hospitals.

The Advanced Vein Visualization instrument is based on basic research conducted and patented by Robert Alfano and Stavros Demos at the Institute for Ultrafast Spectroscopy and Lasers (IUSL) of The City College of New York (CCNY). Their research was assisted by Michele Alfano-Berwanger

Cushman & Wakefield United States

Cushman & Wakefield is a global leader in commercial real estate services, helping clients transform the way people work, shop, and live. The firm’s 43,000 employees in more than 60 countries provides deep local and global insights that create significant value for occupiers and investors around the world.


agency leasing, global occupier services, asset services, investment management (branded DTZ Investors), capital markets, project & development services, facility services (branded C&W Services), tenant representation and valuation & advisory

Mr Bill Hartman
Executive Vice President 

Cydan: Orphan Drug Accelerator United States

Cydan Development is an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential. Cydan focuses on selecting promising assets with well-understood biology and proof-of-concept data in in vivo models from academia, industry and other sources. Data generated during a rigorous de-risking process enables formation of stand-alone companies and strategic partnerships.


Orphan Drugs, Rare Diseases, Genetic Disorders

Ms Vered Bisker-Leib
Chief Business Officer 

CYTOSIAL Biomedic France

CYTOSIAL Biomedic is a pre-clinical medical device startup dedicated to applying its patented chitosan-based breakthrough technology and expertise to the development of medical devices for regenerative medicine and tissue engineering.